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Hypertension remains the most important well-documented, modifiable risk factor for stroke, and treating hypertension is among the most effective 
treatment strategies for preventing both ischemic and 
hemorrhagic stroke.6 Blood pressure instability in the im-
mediate postprocedural period is a common occurrence 
after carotid artery stenosis treatment with either CEA or 
CAS. Hypotension or hypertension can occur, which may 
result in a prolonged hospital stay or neurological com-
plications. However, to the best of our knowledge, the 
long-term effects of CEA or CAS on BP changes have not 
been well evaluated. The aim of this study was to evalu-
ate and compare the long-term effects between CEA and 
CAS on BP.
Methods
This retrospective study was approved by our insti-
tutional review board, and the need for patient informed 
consent was waived. Between January 2003 and Decem-
ber 2009, 134 patients underwent 145 procedures for the 
treatment of carotid artery stenosis by either CEA or CAS. 
Among these patients, those who had at least 1 year of 
clinical and radiographic follow-up after treatment were 
included in this study. After exclusion of 32 patients (23 
patients were lost to follow-up, 6 died, and 3 underwent 
balloon angioplasty only), a total of 102 patients consti-
tuted the population of this study. These patients were 
placed in the CEA group (n = 59) or the CAS group (n = 
43) according to their treatment. Among them, 2 patients 
underwent bilateral CAS, 3 patients underwent bilateral 
CEA, and 1 patient underwent CAS on one side and CEA 
on the other. For the 6 patients who underwent bilateral 
procedures, 2 (4.7%) were included in the CAS group and 
4 (6.8%) were included in the CEA group.
The SBP and DBP were measured at the following 
4 different time points: pretreatment, posttreatment, the 
1-month follow-up, and the 1-year follow-up. Noninvasive 
BP monitoring was used for routine BP measurements. 
The pretreatment, posttreatment, 1-month follow-up, and 
1-year follow-up BPs were calculated by averaging the 
noninvasive BP values for 24 hours at the pretreatment 
Effects of carotid artery stenosis treatment on blood pressure
Clinical article
Joonho Chung, M.D., Ph.D.,1 Byung Moon KiM, M.D.,2 ho Kyu PaiK, M.D.,1 
Dong-Keun hyun, M.D., Ph.D.,1 anD hyeonseon ParK, M.D., Ph.D.1
1Department of Neurosurgery, Inha University School of Medicine and Hospital, Incheon; and 2Department 
of Radiology, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea
Object. The purpose of this study was to evaluate and compare the long-term effects of carotid endarterectomy 
(CEA) and carotid artery stenting (CAS) on blood pressure (BP).
Methods. Between January 2003 and December 2009, 134 patients underwent 145 procedures for treatment of 
carotid artery stenosis. Patients with at least 1 year of clinical and radiographic follow-up after treatment were in-
cluded in this study. A total of 102 patients met this criterion and were placed in the CEA group (n = 59) or the CAS 
group (n = 43) according to their treatment. The percentage change in BP decrement and the number of patients with 
a normotensive BP were evaluated and compared between the groups.
Results. There were no significant differences between the groups with regard to baseline characteristics. Com-
pared with the pretreatment BP, the follow-up BPs were significantly decreased in both groups. At the 1-year follow-
up, the percentage change in the BP decrement was greater in the CAS group (percentage change: systolic BP 9.6% 
and diastolic BP 12.8%) than in the CEA group (percentage change: systolic BP 5.9% [p = 0.035] and diastolic BP = 
8.1% [p = 0.049]), and there were more patients with a normotensive BP in the CAS group (46.5%) than in the CEA 
group (22.0%, p = 0.012).
Conclusions. Both CEA and CAS have BP-lowering effects. Carotid artery stenting seems to have a better effect 
than CEA on BP at the 1-year follow-up.
(http://thejns.org/doi/abs/10.3171/2012.7.JNS112198)
Key WorDs      •      blood pressure      •      carotid artery stenosis      • 
carotid artery stenting      •      carotid endarterectomy      •      vascular disorders
Abbreviations used in this paper: BP = blood pressure; CAS = 
carotid artery stenting; CEA = carotid endarterectomy; DBP = dia-
stolic BP; SBP = systolic BP.
J. Chung et al.
756                                                                                                                      J Neurosurg / Volume 117 / October 2012
and the posttreatment time points, and for 1 month (twice 
a day; immediately after awaking in the morning and be-
fore sleep at night) at the 1-month follow-up period, and 
1 month prior to the 1-year follow-up time point. Before 
the procedure, an assigned nurse measured BP every 2 
hours for 24 hours using an automatic arm manometer. 
After the procedure, the nurse measured BP every hour 
for 8 hours and then every 2 hours for 16 hours. During 
the follow-up period, most of the patients were instructed 
on how to measure their BP in their left arm in the sitting 
position at home with the aid of commercial automatic 
BP measuring equipment.
The average SBP and DBP values at each time point 
were evaluated in each group. In addition, the percentage 
change in the SBP decrement at each time point was cal-
culated using the following equation and was compared 
between the groups: percentage change in SBP decrement 
= {(SBPn - SBP0)/SBPn} × 100, (n = 1, 2, or 3), where SBP0, SBP1, SBP2, and SBP3 represent the pretreatment 
BP, the posttreatment BP, the 1-month follow-up BP, and 
the 1-year follow-up BP, respectively. The percentage 
change in the DBP decrement was calculated using the 
equivalent equation.
A normotensive BP was defined when the SBP/DBP 
decreased to lower than 120/80 mm Hg after the proce-
dures. The number of patients with a normotensive BP 
and the change in the number of antihypertensive drugs 
taken by the patients at each time point were evaluated 
and compared. The antihypertensive drugs consisted of 
diuretics, calcium channel blockers, angiotensin receptor 
blockers, angiotensin-converting enzyme inhibitors, and/
or beta blockers in a single or combined regimen.
Surgical Management
All CEA procedures were performed under gener-
al anesthesia with somatosensory evoked potential and/
or electroencephalography monitoring. If preoperative 
transfemoral cerebral angiography showed that there was 
not enough cross-filling during the Matas Test and the Al-
cock Test, carotid shunts were used during CEA. A local 
lidocaine infiltration at the carotid sinus was performed 
only when the patient’s heart rate was lower than 40 bpm. 
A local injection was performed in 8 (13.6%) of 59 pa-
tients in this study. When closing the carotid artery after 
plaque removal, we preferred continuous-suture closure 
for artery repair rather than carotid patch angioplasty.
Carotid artery stenting was routinely performed af-
ter administration of a local anesthetic and with strict BP 
monitoring. Among the 43 patients enrolled in this study, 
a distal embolic protection device was used in the 38 
most recently treated patients. A self-expanding nitinol 
stent was used for all patients undergoing CAS.
Statistical Analysis
Statistical analyses were conducted using SPSS (ver-
sion 13.0, SPSS, Inc.). We evaluated the significance of 
BP changes between the pretreatment and follow-up peri-
ods by using a paired t-test. The baseline characteristics, 
procedure-related complications, restenosis rates, chang-
es in the number of drugs, and the percentage change in 
BP decrement between the groups were evaluated using 
the Student t-test. Probability values < 0.05 were consid-
ered statistically significant. Mean values are presented 
as the mean ± SD.
Results
The baseline characteristics of each group are shown 
in Table 1. The mean age was younger in the CEA group 
(63.6 ± 7.0 years) than in the CAS group (67.0 ± 8.1 years, 
p = 0.032). Symptomatic lesions were found in 45 patients 
(76.3%) in the CEA group and in 32 patients (74.4%) in 
the CAS group (p = 0.832). The mean stenosis rates were 
81.3% ± 14.4% in the CEA group and 77.5% ± 12.9% in 
the CAS group (p = 0.175). There were no significant dif-
ferences between the groups for the other baseline charac-
teristics, including the presence of hypertension, diabetes, 
hypercholesterolemia, alcohol intake, body mass index, 
atrial fibrillation, or the proportion of the patients who 
underwent bilateral procedures. The mean number of an-
tihypertensive drugs at the pretreatment time point was 
1.29 ± 0.81 in the CEA group and 1.47 ± 0.85 in the CAS 
group (p = 0.290). Procedure-related complications (5.1% 
in the CEA group and 2.3% in the CAS group, p = 0.431) 
and the restenosis rate 1 year after the procedure (1.7% 
in the CEA group and 7.0% in the CAS group, p = 0.483) 
were not significantly different between the groups.
The mean SBPs and DBPs for each time point are 
shown in Fig. 1. Compared with the pretreatment BPs, 
the follow-up BPs were significantly decreased in each 
group after treatment. In the CEA group, the mean SBP/
DBP values were 122.5/73.0, 125.4/75.5, and 129.5/77.7 
mm Hg at the posttreatment time point, the 1-month fol-
low-up, and the 1-year follow-up, respectively. Compared 
with 136.9/83.5 mm Hg at the pretreatment time point, 
the BPs in the CEA group were significantly decreased 
(p < 0.01). In the CAS group, the mean SBP/DBP values 
were 122.7/76.2, 127.2/78.5, and 128.5/77.3 mm Hg at the 
posttreatment time point, the 1-month follow-up, and the 
1-year follow-up, respectively. Compared with 140.7/87.2 
mm Hg at the pretreatment time point, the mean BPs in 
the CAS group were also significantly decreased (p < 
0.01). In both groups, the SBP and DBP were significantly 
decreased after the procedure, and the values tended to 
increase slightly afterward until the 1-year follow-up. The 
follow-up BPs were significantly lower than the pretreat-
ment BPs.
Table 2 shows the percentage changes in the BP dec-
rement at each time point compared with the pretreat-
ment BP. The patients in the CEA group had a 12.6%, 
9.3%, and 5.9% SBP decrement and a 15.9%, 11.8%, and 
8.1% DBP decrement at the posttreatment time point, the 
1-month follow-up, and the 1-year follow-up, respectively. 
The patients in the CAS group had a 15.1%, 11.1%, and 
9.6% SBP decrement and a 15.3%, 11.6%, and 12.8% DBP 
decrement at the posttreatment time point, the 1-month 
follow-up, and the 1-year follow-up, respectively. The 
percentage change in the SBP decrement at the 1-year 
follow-up in the CAS group was greater (p = 0.035) than 
that in the CEA group (Fig. 2). In addition, the percentage 
change in the DBP decrement at the 1-year follow-up in 
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the CAS group was greater (p = 0.049) than that in the 
CEA group.
Compared with pretreatment BP, the CAS group 
comprised a greater percentage of patients with a nor-
motensive BP at the follow-up time points than the CEA 
group (Table 3). At the 1-month follow-up, 29 patients 
(49.2%) in the CEA group and 22 patients (51.2%) in the 
CAS group exhibited a decrease in SBP/DBP to lower 
than 120/80 mm Hg, which was not significantly different 
between the groups (p = 0.695). Yet at the 1-year follow-
up, there were significantly more patients with a normo-
tensive BP in the CAS group (46.5%) than in the CEA 
group (22.0%, p = 0.012). In contrast, 5 patients (8.5%) in 
the CEA group and 2 patients (4.7%) in the CAS group 
had hypertension (SBP/DBP ≥ 140/90 mm Hg) during the 
immediate postprocedural period. At the 1-year follow-
up, postprocedural hypertension occurred in 2.9% of the 
patients overall (2 in the CEA group and 1 in the CAS 
TABLE 1: Baseline characteristics, procedure-related 
complications, and restenosis rate of each group*
Value
Parameter
CEA Group 
(n = 59)
CAS Group 
(n = 43) p Value
mean age (yrs) 63.6 ± 7.0 67.0 ± 8.1 0.032
female 7 (11.9) 11 (25.6) 0.052
rt side 37 (62.7) 16 (37.2) 0.006
symptoms present 45 (76.3) 32 (74.4) 0.832
 bruit 4 (6.8) 1 (2.3)
 retinal 6 (10.2) 4 (9.3)
 hemispheric 38 (64.4) 27 (62.8)
 previous stroke 8 (13.6) 6 (14.0)
mean stenosis rate (%) 81.3 ± 14.4 77.5 ± 12.9 0.175
hypertension 53 (89.8) 33 (76.7) 0.091
diabetes 26 (44.1) 16 (37.2) 0.492
hypercholesterolemia 20 (33.9) 17 (39.5) 0.563
smoking 32 (54.2) 20 (46.5) 0.446 
alcohol 23 (39.0) 19 (44.2) 0.602
mean BMI 24.5 ± 2.4 24.9 ± 2.8 0.486
atrial fibrillation 1 (1.7) 2 (4.7) 0.388
mean no. of pretreatment drugs 1.29 ± 0.81 1.47 ± 0.85 0.290 
no. of procedure-related com- 
 plications
3 (5.1) 1 (2.3) 0.431
  minor 2 (3.4) 1 (2.3)
  major 1 (1.7) 0 (0.0)
restenosis rate 1 (1.7) 3 (7.0) 0.483
* Values are presented as the number of patients (%) unless indicated 
otherwise. Mean values are presented as ± SD. Abbreviation: BMI = 
body mass index.
Fig. 1. Box-and-whisker plots showing the mean noninvasive BP at each time point in the 2 groups. Compared with the 
pretreatment BP, the follow-up BPs were significantly decreased after CEA or CAS. In both groups, the BPs were significantly 
decreased after the procedure, and they tended to increase slightly afterward until the 1-year follow-up. *p < 0.01. Tx = treatment. 
The horizontal lines in the boxes indicate the median. The error bars represent the ranges, and the boxes represent the lower 
quartile (25%) and upper quartile (75%) values.
TABLE 2: Percentage changes of the BP decrements between 
groups*
% Change
BP & Time Points CEA Group CAS Group p Value
SBP
 post-Tx 12.6 15.1 0.253
 1 mo 9.3 11.1 0.340
 1 yr 5.9 9.6 0.035
DBP
 post-Tx 15.9 15.3 0.854
 1 mo 11.8 11.6 0.952
 1 yr 8.1 12.8 0.049
* Tx = treatment.
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group). The number of antihypertensive drugs taken by 
the patients was not significantly changed at the follow-up 
time points.
Compared with the mean number of pretreatment 
drugs taken, there were no significant changes at the 
follow-up time points (1-month and 1-year follow-up) be-
tween the groups. However, 2 patients (4.7%) in the CAS 
group and 18 patients (30.5%) in the CEA group (p = 
0.043) at the 1-year follow-up were taking more antihy-
pertensive drugs (Table 4).
Discussion
Carotid artery stenosis can currently be treated using 
CEA or CAS. During these procedures, periprocedural 
hemodynamic instabilities, such as hypotension, brady-
cardia, or hypertension, are often encountered.1,11–14,17,20 
Hypertension has been noted with a frequency of 9%–
38% after CEA18,20 and 39% after CAS.16 A wide variation 
in the frequency of hypotension has been observed af-
ter CEA (12%–50%)2,20 and after CAS (18.8%–56.1%).4,8 
Since there are few reports for the long-term follow-up of 
BP changes after treatment of carotid artery stenosis, we 
evaluated the long-term effects of carotid artery stenosis 
treatment on BP, and we compared the effects between 
CEA and CAS.
In this study, a low frequency of episodes of in-
creased BP was noted at the 1-year follow-up (2.9% of 
the patients with SBP/DBP > 140/90 mm Hg), but a much 
higher frequency of episodes of normotensive BP (SBP/
DBP < 120/80 mm Hg) was observed at the 1-year follow-
up (22.0% after CEA and 46.5% after CAS, Table 3). The 
CAS group showed a greater frequency of normotensive 
BP than the CEA group. Although the pretreatment BP 
was slightly lower in the CEA group, the 1-year follow-
up BP was lower in the CAS group (Fig. 1). In addition, 
the percentage changes of SBP and DBP were greater in 
the CAS group at the 1-year follow-up than in the CEA 
group, indicating that CAS has a greater tendency for BP-
lowering effects than CEA.
Damage to the carotid baroreceptor is an important 
cause of periprocedural hemodynamic instability. The 
adventitial baroreceptors in the carotid sinus, which is the 
dilated segment of the internal carotid artery at its origin 
from the common carotid artery, are stretch receptors. 
The arterial wall of the carotid sinus is thinner than that 
of other arteries of the same caliber. Increased firing of 
these baroreceptors inhibits sympathetic neurons in the 
tractus solitarius nucleus, which reduces the sympathetic 
Fig. 2. Box-and-whisker plots showing the percentage change in BP decrement in the 2 groups. At the 1-year follow-up, the 
percent change of the BP in the CAS group was greater than that in the CEA group. The horizontal lines in the boxes indicate the 
median. The error bars represent the ranges, and the boxes represent the lower quartile (25%) and upper quartile (75%) values.
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tone in the peripheral blood vessels, leading to a reduc-
tion in systemic BP. Atherosclerosis and hypertension 
lower the baroreceptors’ sensitivity because the carotid 
sinus becomes stiffer and more resistant to deformation. 
In this study, it might be suggested that CAS has a greater 
tendency for a BP-lowering effect, possibly because of 
greater compliance and an increase in the diameter of 
the arterial segment after the angioplasty. Furthermore, 
the radial force of the stent imparts chronic mechanical 
pressure over the carotid sinus.1 On the other hand, even 
though CEA can result in optimal BP control in a patient 
with treatment-resistant hypertension,9 CEA may induce 
the surgical denervation of the carotid sinus nerve or in-
duce dysfunction of the carotid baroreceptors during the 
procedure, leading to less reduction in BP at the long-
term follow-up.
In this study, more patients had carotid artery steno-
sis on the right side in the CEA group (62.7%) than in the 
CAS group (25.6%, p = 0.006). The difference in the later-
ality of the carotid artery stenosis might affect the results 
of this study since some studies in humans have suggest-
ed some laterality of the carotid sinus output. Williamson 
et al.19 suggested that afferent input from the left carotid 
sinus might have a greater influence on efferent muscle 
sympathetic outflow. Diedrich et al.5 suggested the pres-
ence of a right-sided lateralization of carotid baroreceptor 
output. These authors concluded that right lateralization 
of the sympathetic activity to the vessels is indicated by 
normalized burst strength parameters of bilateral mus-
cle sympathetic nerve activity recordings. According to 
their study, treating one side of the carotid artery stenosis 
might have a greater BP-lowering effect than treating the 
other side. On the other hand, Furlan et al.7 concluded 
that there was no asymmetry in the neural sympathetic 
discharge responses after single-sided carotid barorecep-
tor stimulation. In this study, BP-lowering effects were 
observed in both groups despite the fact that there were 
more left-sided lesions in the CAS group than the CEA 
group. In addition, there was insufficient evidence to ex-
plain why the lateralization of the carotid sinus output 
had a better long-term (1-year follow-up) BP-lowering ef-
fect in the CAS group. Overall, a complete understanding 
of the lateralization of the carotid sinus output is difficult 
to arrive at from the current data.
Blood pressure management plays a crucial role in 
the prevention of stroke. Any decrease in BP is associated 
with a decrease in the relative risk of stroke.10 A study 
of antihypertensive treatment in patients with a history 
of cerebrovascular events found that a reduction of 9/4 
mm Hg was associated with a reduced risk of stroke of 
28%, so even small decreases in BP are highly effective.15 
In this study, the long-term effect of CAS is associated 
with greater sustained reduction of BP than that associ-
ated with CEA, which means that CAS may have better 
effects on BP control than CEA after treating carotid ar-
tery stenosis. Therefore, CAS may have a better effect on 
the secondary prevention of stroke than CEA, and it may 
be worth further studying the effect of this greater BP 
lowering of CAS than CEA on the secondary prevention 
of stroke.
Even though there were some changes in the number 
of antihypertensive drugs taken by the patients in each 
group during the follow-up periods, there were no sig-
nificant differences between the groups except for the 
numbers of the drugs that were being taken at the 1-year 
follow-up (Table 4). More patients in the CEA group 
(30.5%) were taking antihypertensive drugs at the 1-year 
follow-up than those in the CAS group (4.7%, p = 0.043). 
However, CAS treatment had a longer-term effect on BP 
control than CEA treatment, which indicated that the 
number of antihypertensive drugs may not affect the BP-
lowering effect of carotid artery stenosis treatment.
The limitations of this study include its retrospective 
design, which excluded randomization and access to cer-
tain data. It was very difficult, for example, to analyze the 
dosage changes of the antihypertensive drugs, and there-
fore such an analysis was not done in this study. Some 
previous studies excluded patients who changed their an-
tihypertensive drugs.11 However, we analyzed the chang-
es in the number of drugs, and we attempted to evaluate 
the correlation between the number of antihypertensive 
drugs and the BP-lowering effects. Finally, we examined 
the average of the noninvasive BP values rather than am-
bulatory BP values.3,21 Noninvasive BP measurements 
are less reliable than ambulatory BP measurements as a 
representative measure. We routinely educate patients to 
check their BP twice a day to control their BP during the 
follow-up period. To help eliminate factors that reduce the 
reliability of single blood pressure values, the BPs were 
calculated by averaging the noninvasive BP values for 24 
hours pre- and posttreatment, and for 1 month (twice a 
day) at the 1-month follow-up and the 1-year follow-up.
TABLE 3: Number of patients with normotensive BP at the 
follow-up time points*
No. of Patients (%)
Time Point
CEA Group 
(n = 59)
CAS Group 
(n = 43) p Value
1-mo follow-up 29 (49.2) 22 (51.2) 0.695
1-yr follow-up 13 (22.0) 20 (46.5) 0.012
* Normotensive BP is lower than 120/80 mm Hg.
TABLE 4: Changes in the number of antihypertensive drugs 
taken at the follow-up time points
No. of Patients (%)
Time Point & No. of Drugs
CEA Group 
(n = 59)
CAS Group 
(n = 43) p Value
1-mo follow-up
 same 34 (57.6) 33 (76.7) 0.116
 increased 22 (37.3) 3 (7.0) 0.052
 decreased 3 (5.1) 7 (16.3) 0.074
1-yr follow-up
 same 34 (57.6) 28 (65.1) 0.208
 increased 18 (30.5) 2 (4.7) 0.043
 decreased 7 (11.9) 13 (30.2) 0.085
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Conclusions
Both CEA and CAS have BP-lowering effects. Ca-
rotid artery stenting seems to have a better effect than 
CEA on the BP decrement at the 1-year follow-up after 
the procedure. A randomized double-blind study is ex-
pected to demonstrate a certain association between the 
BP-lowering effect and carotid artery stenosis treatment.
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